Chr. Hansen announces "strong" results

19 Oct 2018

Chr. Hansen has announced that it achieved “strong” results in 2017/18, and growth is set to continue in 2018/19. For the full year, organic growth was 9%. For the fourth quarter, organic growth was 10%.

Chr. Hansen announces strong results

Chr. Hansen has announced that it achieved “strong” results in 2017/18, and growth is set to continue in 2018/19. For the full year, organic growth was 9%, and adjusting for a negative currency impact of 6%, corresponded to a revenue increase of 3% to €1,097 million. Food Cultures & Enzymes saw 12% organic growth, while Health & Nutrition achieved 8% organic growth. Natural Colours grew organically by 5%.

For the fourth quarter, organic growth was 10%, and adjusting for a negative currency impact of 5%, corresponded to a revenue increase of 5% to €297 million. Food Cultures & Enzymes saw 12% organic growth; Health & Nutrition achieved 10% organic growth; and Natural Colors saw 6% organic growth.

CEO Mauricio Graber said: “2017/18 was another good year for Chr. Hansen, and we finished strongly in Q4 driven by Food Cultures & Enzymes and Health & Nutrition. We achieved all the overall financial targets that we set at the beginning of the year, in spite of currency headwinds impacting both revenues and earnings, with organic growth reaching 9%, EBIT margin before special items increasing to 29.2%, and free cash flow before special items and acquisitions increasing by 4% to EUR 196 million. For the full year, Food Cultures & Enzymes delivered strong growth organic of 12%, performing well above the long-term ambition of growing 7-8% per year, while Health & Nutrition and Natural Colors delivered moderate growth and grew by 8% and 5%, respectively.”

2017/18 was also a good year from a strategic perspective: We updated our strategy to become Nature’s no. 1 Sustainably and set a new financial ambition to take us to 2021/22. We reconfirmed that the products behind 82% of our revenues directly support three of the 17 UN Sustainability Development Goals. We began utilizing our new fermentation capacity in Copenhagen, which is the largest and most modern culture production plant in the world. Our three lighthouse projects each showed great progress through the year. Revenue in bioprotection grew around 35% and with the second-generation products showing impressive early progress.”

“The key focus for Chr. Hansen in 2018/19 will be to continue to execute the Nature’s no. 1 Sustainably strategy and to bring strong organic growth through innovation.”

The company’s outlook for the coming year sees it expecting to achieve organic revenue growth in the range 9-11%.

Read more about Chr. Hansen

Related news

Study: AstaPure Arava is highly potent

Study: AstaPure Arava is highly potent

13 Feb 2019

The results of a new study are said to indicate that Algatechnologies’ AstaPure Arava algae powder is highly potent and has synergistic effects of the natural astaxanthin and the whole-algae complex.

Read more 
Study: Neumentix enhances physical performance

Study: Neumentix enhances physical performance

12 Feb 2019

A new study published in the Journal of the International Society of Sports Nutrition shows Neumentix, the nootropic ingredient from Kemin Human Nutrition and Health, can enhance physical performance through cognitive improvements.

Read more 
MycoTechnology gets $30 million in new investment

MycoTechnology gets $30 million in new investment

1 Feb 2019

MycoTechnology has received $30 million in new investment that it says will fuel expansion and accelerate R&D project execution.

Read more 
GSK, Pfizer to combine on consumer health

GSK, Pfizer to combine on consumer health

31 Dec 2018

GlaxoSmithKline (GSK) has reached agreement with Pfizer to combine their consumer health businesses into a new joint venture, with combined sales of approximately £9.8 billion ($12.7 billion).

Read more 
DuPont talks probiotics to Chinese physicians

DuPont talks probiotics to Chinese physicians

17 Dec 2018

DuPont Nutrition & Health recently presented on the latest developments on clinical research, market insights and trends on global probiotics products at the 3rd Probiotics and Health Medical Science Summit.

Read more 
Nuts gain from awareness of healthy fats

Nuts gain from awareness of healthy fats

19 Nov 2018

Demand for products containing nuts is on the rise, aided by ongoing research into their health benefits and growing consumer understanding of healthy fats.

Read more 
Cranberries show promise for improved gut health

Cranberries show promise for improved gut health

19 Nov 2018

Researchers are just beginning to understand the link between the gut and many chronic health conditions, leading to growing interest in prebiotic ingredients. According to a new study, cranberries are the latest food to show prebiotic potential.

Read more 
Mintel identifies three trends for 2019

Mintel identifies three trends for 2019

15 Nov 2018

Mintel has announced three forward-looking trends which it believes will lead the momentum of global food and drink innovation in 2019 and beyond.

Read more 
Innova announces Top 10 Trends for 2019

Innova announces Top 10 Trends for 2019

14 Nov 2018

“Discovery: The Adventurous Consumer” leads the list of Innova Market Insights’ Top Ten Trends for 2019 which it will discuss in a webinar on November 21.

Read more 
Egg substitutes driven by vegan, allergen-free demand

Egg substitutes driven by vegan, allergen-free demand

13 Nov 2018

Egg replacers have long been used as a way to avoid to the price fluctuations often associated with real eggs, but recently interest has been driven by manufacturer demand for clean label and plant-based ingredients, allowing companies to make more veg...

Read more